机译:新的非白痴维生素D受体调节剂联合吉西他滨,通过重塑肿瘤微环境来增强胰腺癌治疗
China Pharmaceut Univ Ctr Adv Pharmaceut &
Biomat State Key Lab Nat Med Jiangsu Key Lab Drug Discovery Metab Dis Nanjing 210009 Peoples R China;
China Pharmaceut Univ Ctr Adv Pharmaceut &
Biomat State Key Lab Nat Med Jiangsu Key Lab Drug Discovery Metab Dis Nanjing 210009 Peoples R China;
China Pharmaceut Univ Ctr Adv Pharmaceut &
Biomat State Key Lab Nat Med Jiangsu Key Lab Drug Discovery Metab Dis Nanjing 210009 Peoples R China;
China Pharmaceut Univ Ctr Adv Pharmaceut &
Biomat State Key Lab Nat Med Jiangsu Key Lab Drug Discovery Metab Dis Nanjing 210009 Peoples R China;
China Pharmaceut Univ Ctr Adv Pharmaceut &
Biomat State Key Lab Nat Med Jiangsu Key Lab Drug Discovery Metab Dis Nanjing 210009 Peoples R China;
China Pharmaceut Univ Ctr Adv Pharmaceut &
Biomat State Key Lab Nat Med Jiangsu Key Lab Drug Discovery Metab Dis Nanjing 210009 Peoples R China;
China Pharmaceut Univ Ctr Adv Pharmaceut &
Biomat State Key Lab Nat Med Jiangsu Key Lab Drug Discovery Metab Dis Nanjing 210009 Peoples R China;
China Pharmaceut Univ Ctr Adv Pharmaceut &
Biomat State Key Lab Nat Med Jiangsu Key Lab Drug Discovery Metab Dis Nanjing 210009 Peoples R China;
China Pharmaceut Univ Ctr Adv Pharmaceut &
Biomat State Key Lab Nat Med Jiangsu Key Lab Drug Discovery Metab Dis Nanjing 210009 Peoples R China;
China Pharmaceut Univ Ctr Adv Pharmaceut &
Biomat State Key Lab Nat Med Jiangsu Key Lab Drug Discovery Metab Dis Nanjing 210009 Peoples R China;
China Pharmaceut Univ Ctr Adv Pharmaceut &
Biomat State Key Lab Nat Med Jiangsu Key Lab Drug Discovery Metab Dis Nanjing 210009 Peoples R China;
机译:摘要408:ACP-196,BTK的口服生物可利用的共价选择性抑制剂调节先天肿瘤微环境,表现出抗肿瘤疗效,增强胰腺癌中的吉西他滨活性(R-75,PG 18,2015的收缩)
机译:通过靶向阻断肿瘤免疫细胞对肿瘤相关巨噬细胞的PI3K-GAMMA和CSF-1 / CSF-1R途径进行重塑肿瘤免疫微环境进行胰腺癌治疗
机译:信号转导和转录激活剂3,肿瘤微环境的介导重塑导致胰腺癌小鼠模型中肿瘤药物传递的增强
机译:纳秒脉冲电场联合吉西他滨作为潜在的乳腺癌治疗方法
机译:使用吉西他滨纳米粒改良的胰腺癌治疗
机译:STAT3介导的肿瘤微环境重塑导致胰腺癌小鼠模型中增强的肿瘤药物传递。
机译:新的非白痴维生素D受体调节剂联合吉西他滨通过重塑肿瘤微环境来增强胰腺癌治疗
机译:缺氧在肿瘤微环境中的作用:卵巢癌治疗的意义。